Neurocrine Biosciences
NBIX
#1429
Rank
โ‚น1.491 T
Marketcap
โ‚น14,833
Share price
-0.30%
Change (1 day)
40.93%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2026 (TTM): โ‚น71.58 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are โ‚น3.10 Billion. In 2025 the company made an earning of โ‚น61.22 Billion, an increase over its 2024 earnings that were of โ‚น58.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น71.58 B16.92%
2025 โ‚น61.22 B3.9%
2024 โ‚น58.92 B96.41%
2023 โ‚น30.00 B41.13%
2022 โ‚น21.25 B73.74%
2021 โ‚น12.23 B-8.82%
2020 โ‚น13.41 B77.78%
2019 โ‚น7.54 B49.83%
2018 โ‚น5.03 B-142.57%
2017 -โ‚น11.84 Billion-14.73%
2016 -โ‚น13.88 Billion53.15%
2015 -โ‚น9.07 Billion46.25%
2014 -โ‚น6.2 Billion29.66%
2013 -โ‚น4.78 Billion-3530.8%
2012 โ‚น0.13 B-95.73%
2011 โ‚น3.26 B
2009 -โ‚น4.59 Billion-45.38%
2008 -โ‚น8.4 Billion-58.87%
2007 -โ‚น20.42 Billion87.3%
2006 -โ‚น10.9 Billion351.97%
2005 -โ‚น2.42 Billion-52.09%
2004 -โ‚น5.04 Billion-10.98%
2003 -โ‚น5.66 Billion
2001 -โ‚น4.23 Billion
1999 -โ‚น1.91 Billion108.32%
1998 -โ‚น0.92 Billion
1996 โ‚น0.27 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.018 T 1,225.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น634.56 B 725.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.993 T 3,796.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น8.06 B-89.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น4.02 Billion-105.23%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น9.21 B-88.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น0.47 Billion-100.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚น163.05 B 112.21%๐Ÿ‡ฌ๐Ÿ‡ง UK